ArticleJournal of Yeungnam medical science2025
Feasibility and construct validity evaluation of remote neuropsychological testing using the K-eRBANS: a preliminary single group prospective observational study.
Article in Journal of Yeungnam medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study evaluated the feasibility and construct validity of the Korean electronic version of the Repeatable Battery for the Assessment of Neuropsychological Status (K-eRBANS), a tablet-based neuropsychological test designed for remote cognitive screening for the prevention and early detection of dementia.
methodsThe K-eRBANS was administered remotely using paired examiner-participant tablets with automated scoring and secure data transmission. The system was interoperable with the Clinical Data Interchange Standards Consortium (CDISC)-compliant Korean dementia standard database. Concurrent validity was examined against the Korean Mini-Mental State Examination-2 (K-MMSE-2) and Clinical Dementia Rating (CDR). Construct validity was tested using confirmatory factor analysis (CFA) of the theoretical five-factor model.
resultsA total of 150 participants (mean age, 55.0±6.5 years; 24.7% male) completed testing. Cognitive performance was generally preserved with slightly lower visuospatial/constructional abilities (mean, 83.66; standard deviation, 21.95). K-eRBANS scores were positively correlated with K-MMSE-2 (r=0.223-0.577, p<0.01) and negatively with CDR (r=-0.118 to -0.414, p<0.01). CFA results supported the hypothesized five-factor model (χ²=104.44; chi-square to degrees of freedom ratio, 2.13; root mean square error of approximation, 0.089; comparative fit index, 0.910; Tucker-Lewis index, 0.879), indicating acceptable model fit.
conclusionThe findings demonstrate that K-eRBANS is a feasible, reliable, and psychometrically valid digital neuropsychological tool that preserves the structural integrity of the original, nonelectronic version of the tool. Its integration with the CDISC-aligned databases enables scalable remote cognitive assessment and supports data-driven dementia prevention within Korea's national dementia care framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.